Discovery & Innovation

Academic medical centers (AMCs) are among the United States’ most active hives of biomedical innovation thanks to their often robust research enterprises. Increasingly, AMCs like the Heersink School of Medicine play a central role in another realm of innovation: the biomedical/biotech start-up space.

In the early 1980s, a hit TV show introduced many Americans to artificial intelligence (AI). While Michael Knight, famously portrayed by David Hasselhoff, was technically the main character of “Knight Rider,” it was KITT, a black 1982 Pontiac Trans Am with the power to think and talk, that spurred fans of the show to tune in week after week.

“Alabama is a hotbed for fungal diseases,” said Peter Pappas, M.D., professor in the Division of Infectious Diseases in the Heersink School of Medicine. “We see as much or more in the way of fungal infections as anyone in the country.” Pappas is a leader of the Mycoses Study Group, a world-renowned, UAB administered group of experts who focus on understanding and treating invasive fungal infections and have led most of the clinical trials for FDA-approved antifungal treatments. (Mycology is the study of fungi; mycoses are invasive fungal infections.)

A nationwide study of 196 cities shows that housing discrimination from 90 years ago still casts a shadow of inequities in colon cancer care today, S.M. Qasim Hussaini, M.D., assistant professor in the Division of Hematology and Oncology, and colleagues at the American Cancer Society and Johns Hopkins School of Public Health reported in the journal JCO Oncology Practice.